IGM Biosciences (IGMS) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -2.98 | -30.4 | -4.96 | -1.45 | -0.54 | -0.51 | ||
| Changes by years, y/y, % | +2 033% | +920% | -84% | -71% | -62% | +31.2% | |||
IGM Biosciences. EV/EBITDA
IGM Biosciences. EV/EBITDA, changes, %
IGM Biosciences (IGMS) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EV/EBITDA | ? | -0.61 | -0.78 | -1.33 | -0.87 | -3.67 | -0.51 | |
| Changes by years, y/y, % | -76% | -52% | +12% | +196% | +501% | |||
| Changes by quarters, q/q, % | +109% | +28% | +71% | -35% | +324% | |||